Latanoprostene Bunod 0.024% Early Experience Program (LEEP): A Canadian Initiative for Open-Angle Glaucoma and Ocular Hypertension

Abstract Introduction Here we report the intraocular pressure (IOP) changes following treatment with latanoprostene bunod (LBN) 0.024% in patients in Canadian ophthalmology practices. Methods This real-world, open-label, 6-week, observational study collected data from 59 Canadian ophthalmologists an...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	David Yan, Cindy M. L. Hutnik, Paul Harasymowycz
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Adis, Springer Healthcare 2025-04-01
Schriftenreihe:	Ophthalmology and Therapy
Schlagworte:	Intraocular pressure Latanoprostene bunod Open-angle glaucoma Ocular hypertension Nitric oxide donor Patient satisfaction
Online-Zugang:	https://doi.org/10.1007/s40123-025-01132-z
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!